BeStock  
Stocks › Biotechnology › VALN

Valneva VALN

US equityMarket cap rank #3599Biotechnology
$5.16 −$0.21 (-3.82%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.16 0.00%
Open$5.30
Prev close$5.37
Day range$5.11 – $5.30
Volume17.6K
Market cap$490.86M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026 · reported in EUR

Revenue€34.94M-27.7% YoY
Operating profit-€26.17M-146.0% YoY
Net profit-€31.20M-169.3% YoY
Diluted EPS-€0.34-142.9% YoY
Free cash flow-€13.77M-240.0% YoY
Operating cash flow-€13.43M

Revenue, last 8 quarters

€45.8MSep '24€52.9MDec '24€49.2MMar '25€48.3MJun '25€29.4MSep '25€47.7MDec '25€30.9MMar '26€34.9MJun '26

Net profit, last 8 quarters

€-9.2MSep '24€-37.0MDec '24€-9.2MMar '25€-11.6MJun '25€-44.4MSep '25€-50.0MDec '25€-32.1MMar '26€-31.2MJun '26

Diluted EPS by quarter

-0.14Sep '24-0.52Dec '24-0.12Mar '25-0.14Jun '25-0.52Sep '25-0.58Dec '25-0.36Mar '26-0.34Jun '26

Free cash flow by quarter

€-26.4MSep '24€13.2MDec '24€-9.6MMar '25€-4.1MJun '25€-18.1MSep '25€-25.6MDec '25€-565.0KMar '26€-13.8MJun '26

Annual revenue

€110.3MFY20€348.1MFY21€361.3MFY22€153.7MFY23€169.6MFY24€174.7MFY25

Profitability & balance sheet

Gross margin16.4%
Operating margin-80.4%
Net margin-110.3%
Return on equity-117.8%
Return on assets-36.6%
Return on invested capital-37.9%
Current ratio2.16
Liabilities / assets79.1%
Cash & investments€121.53M
Total debt€207.50M
Net cash (debt)-€85.98M

Where the revenue comes from

Quarter 2025/FY

By business line

  • IXIARO€98.42M 56.3%
  • DUKORAL€31.91M 18.3%
  • Third party products€19.16M 11.0%
  • R&D work and additional support services€9.99M 5.7%
  • IXCHIQ€8.42M 4.8%
  • Milestone payment - licenses€3.42M 2.0%
  • Royalties received€2.12M 1.2%
  • Other non - International Financial Reporting Standards (IFRS) 15 revenue€653,000.00 0.4%
  • Revenues from shipping and handling€481,000.00 0.3%
  • Other€87,000.00 0.0%

By region

  • United States€53.61M 30.7%
  • Canada€30.13M 17.2%
  • Germany€17.47M 10.0%
  • France€14.67M 8.4%
  • Nordics€13.90M 8.0%
  • Other Europe€13.88M 7.9%
  • United Kingdom€12.64M 7.2%
  • Austria€9.47M 5.4%
  • Rest of world€8.90M 5.1%

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Income statement

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Total Revenue as Reported €34.94M €30.90M €174.66M €47.69M €29.41M
Total Operating Revenue €34.94M €30.90M €174.66M €47.69M €29.41M
Cost of Revenue €33.34M €26.18M €107.14M €36.07M €23.91M
Gross Profit €1.60M €4.72M €67.52M €11.62M €5.50M
Operating Expense €27.77M €28.42M €149.15M €39.30M €42.85M
Selling and Admin Expenses €13.77M €15.14M €74.68M €16.54M €18.80M
-Selling & Marketing Expense €6.50M €6.97M €37.36M €8.74M €8.31M
-General & Admin Expense €7.27M €8.17M €37.32M €7.80M €10.49M
Research & Development €15.02M €15.22M €85.30M €25.57M €27.29M
Other Operating Expenses -€1.16M -€1.93M -€11.20M -€3.18M -€3.02M
Operating Profit -€26.17M -€23.70M -€81.63M -€27.69M -€37.35M
Net Non-Operating Interest Income (Expense) -€5.54M -€4.57M -€39.25M -€23.87M -€4.87M
Non-Operating Interest Income -€339,000.00 €526,000.00 €1.80M -€70,000.00 €845,000.00
Non-Operating Interest Expense €5.20M €5.09M €41.90M €24.64M €5.67M
Other Income (Expense) -€59,000.00 -€2.99M €6.77M €475,000.00 -€1.26M
Gain on Sale of Security -€44,000.00 -€2.99M €7.20M €906,000.00 -€1.49M
Pretax Profit -€31.77M -€31.25M -€114.12M -€51.08M -€43.47M
Tax -€566,000.00 €824,000.00 €1.07M -€1.06M €882,000.00
Net Profit -€31.20M -€32.07M -€115.19M -€50.02M -€44.36M
Profit from Continuing Operations -€31.20M -€32.07M -€115.19M -€50.02M -€44.36M
Net Income to Parent Company -€31.20M -€32.07M -€115.19M -€50.02M -€44.36M
Net Income to Common Stockholders -€31.20M -€32.07M -€115.19M -€50.02M -€44.36M
Basic EPS -€0.34 -€0.36 -€1.36 -€0.58 -€0.52
Diluted EPS -€0.34 -€0.36 -€1.36 -€0.58 -€0.52
Other Taxes – – €373,000.00 – –
Total Other Finance Costs – – -€841,000.00 – –
Special Income (Charges) – – -€431,000.00 – –
-Less:Other Special Charges – – -€1,000.00 – –
-Gain on Sale of Property/Plant/Equipment – – -€432,000.00 – –

Balance sheet

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Total Assets €388.28M €372.01M €398.84M €398.84M €448.23M
Total Current Assets €222.88M €201.44M €222.54M €222.54M €268.33M
Cash and Cash Equivalents & Short-Term Investments €121.53M €105.27M €109.65M €109.65M €143.46M
-Cash and Cash Equivalents €121.53M €105.27M €109.65M €109.65M €143.46M
Receivables €16.34M €10.13M €27.81M €27.81M €20.08M
-Accounts Receivable €16.26M €10.13M €27.73M €27.73M €20.08M
-Other Receivables €78,000.00 – €80,000.00 €80,000.00 –
Inventory €48.16M €50.58M €50.23M €50.23M €64.29M
Other Current Assets €35.03M €35.46M €34.85M €34.85M €40.50M
Total Non-Current Assets €165.40M €170.57M €176.30M €176.30M €179.90M
Net PPE €128.48M €133.61M €138.03M €138.03M €142.07M
-Gross PPE €128.48M €133.61M €247.92M €247.92M €142.07M
Goodwill and Other Intangible Assets €20.91M €21.63M €22.35M €22.35M €23.07M
Non-Current Deferred Assets €8.46M €7.76M €8.33M €8.33M €7.34M
Other Non-Current Assets €7.55M €7.58M €7.59M €7.59M €7.42M
Total Liabilities €307.16M €295.31M €292.67M €292.67M €297.75M
Total Current Liabilities €103.33M €94.22M €93.33M €93.33M €150.48M
Payables €32.56M €44.17M €15.99M €15.99M €49.11M
-Accounts Payable €10.92M €21.81M €9.07M €9.07M €30.12M
-Total Tax Payable €21.64M €22.36M €6.91M €6.91M €18.99M
Current Accrued Expenses €11.99M – €15.47M €15.47M –
Short-Term Debt and Capital Lease Obligation €21.16M €21.01M €20.64M €20.64M €61.51M
-Current Debt €18.43M €18.27M €17.91M €17.91M €58.83M
-Current Capital Lease Obligation €2.73M €2.74M €2.74M €2.74M €2.67M
Current Provisions €30.80M €23.20M €22.47M €22.47M €31.91M
Current Deferred Liabilities €482,000.00 €427,000.00 €432,000.00 €432,000.00 €423,000.00
Other Current Liabilities €6.35M €5.41M €5.69M €5.69M €7.53M
Total Non-Current Liabilities €203.82M €201.10M €199.33M €199.33M €147.27M
Long Term Debt and Capital Lease Obligation €189.07M €188.49M €186.60M €186.60M €134.34M
-Long Term Debt €165.63M €164.06M €161.26M €161.26M €108.89M
-Long Term Capital Lease Obligation €23.44M €24.43M €25.34M €25.34M €25.45M
Non-Current Liabilities €7.91M €7.93M €8.08M €8.08M €8.96M
Non-Current Deferred Liabilities €4.46M €4.43M €4.41M €4.41M €3.95M
Other Non-Current Liabilities €2.37M €240,000.00 €245,000.00 €245,000.00 €29,000.00
Total Equity €81.12M €76.70M €106.17M €106.17M €150.48M
Stockholders' Equity €81.12M €76.70M €106.17M €106.17M €150.48M
Capital Stock €28.47M €26.08M €26.03M €26.03M €25.78M
-Common Stock €28.47M €26.08M €26.03M €26.03M €25.78M
Additional Paid-In Capital €704.52M €676.82M €675.94M €675.94M €672.42M
Retained Earnings -€742.40M -€711.19M -€679.12M -€679.12M -€629.10M
Less: Treasury Stock -€645,000.00 – -€645,000.00 -€645,000.00 –
Gains/Losses Not Affecting Retained Earnings €44.59M €84.99M €40.74M €40.74M €81.38M
Other Equity Interests €46.59M – €43.22M €43.22M –
-Accumulated Depreciation – – -€109.89M -€109.89M –
-Other Intangible Assets – – €22.35M €22.35M –

Cash flow

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Operating Cash Flow -€13.43M -€313,000.00 -€52.89M -€24.51M -€17.44M
Net cash flow from continuing operations -€13.43M -€314,000.00 -€52.90M -€24.51M -€17.44M
Net Income from Continuing Operations -€31.20M -€32.07M -€115.19M -€50.02M -€44.36M
Other Non-Cash Items €1.30M €14.54M €30.40M -€5.71M €34.74M
Change in Working Capital €4.88M €17.22M -€148,000.00 -€2.89M €10.53M
Net cash flow from investing €356,000.00 €275,000.00 -€1.71M -€264,000.00 €197,000.00
Net Cash Flow from Continuing Investing Activities €357,000.00 €274,000.00 -€1.71M -€264,000.00 €197,000.00
Net PPE Purchase and Sale -€177,000.00 -€247,000.00 -€4.29M -€1.04M -€611,000.00
Net Intangibles Purchase and Sale €0.00 -€5,000.00 -€61,000.00 €0.00 €0.00
Net Investment Purchase and Sale €436,000.00 €437,000.00 €841,000.00 – –
Financing Cash Flow €29.18M -€4.69M -€621,000.00 -€9.36M -€556,000.00
Net Cash Flow from Continuing Financing Activities €29.18M -€4.69M -€622,000.00 -€9.37M -€557,000.00
Net Issuance Payments Of Debt -€676,000.00 -€1.20M €61,000.00 €3.52M -€2.08M
Net Common Stock Issuance €34.38M €920,000.00 €30.00M €3.76M €6.11M
Cash Dividends Paid €0.00 €0.00 €0.00 €0.00 €0.00
Ending Cash Balance €121.53M €105.27M €109.65M €109.65M €143.46M
Net Change in Cash €16.11M -€4.73M -€55.22M -€34.13M -€17.80M
Beginning Cash Balance €105.27M €109.65M €168.27M €143.46M €161.31M
Effect of Exchange Rate Changes €155,000.00 €342,000.00 -€3.40M €322,000.00 -€42,000.00
Free Cash Flow -€13.77M -€565,000.00 -€57.38M -€25.59M -€18.11M
Net Other Investing Changes – €1,000.00 – – –
Net Other Financing Charges – €1,000.00 €1,000.00 – –
Gain/Loss from Continuing Operations – – €999,000.00 – –
Depreciation & Depletion & Amortization – – €21.75M – –
Deferred Tax – – €1.07M – –
-Change in Receivables – – €13.33M – –
-Change in Inventory – – €1.03M – –
-Change in Payables and Accrued Expense – – -€4.46M – –
-Change in Other Current Assets – – €446,000.00 – –
-Change in Other Current Liabilities – – -€7.90M – –
-Change In Other Working Capital – – -€2.60M -€5.34M €5.24M
Net Business Purchase and Sale – – €0.00 – –

Discussion

No comments yet — be the first to weigh in on VALN.

Sign in to join the discussion.

Scroll to Top